Trial of Efficacy of Gamegear Headgear using NIA technology in Concussion

Gamegear Holdings is working with Connectivity to reduce the incidence and long-term impact of concussion. Together we are launching a landmark research trial on the efficacy of the Gamegear Headgear using NIA technology (Nodal Impact Attenuation) in reducing the incidence and/or severity of concussion in adult athletes.

The below research call has now closed. The successful application will be announced in February 2026.

 

RESEARCH CALL

On behalf of Gamegear Holdings (ABN 684 505 600), Connectivity Traumatic Brain Injury Australia is pleased to call for proposals to conduct a Trial to evaluate the efficacy of the Gamegear Headgear using NIA technology (Nodal Impact Attenuation) in reducing the incidence and/or severity of concussion in adult athletes.

One proposal will be selected to conduct a Project to perform a Trial, with funding provided of $400,000 per annum, for two years, totalling $800,000.

Purpose of the Trial

The Trial must be designed to:

(i) determine whether the Gamegear Headgear using NIA technology reduces the incidence of concussion in athletes relative to athletes not wearing a helmet, and

(ii) determine whether the Gamegear Headgear using NIA technology reduces the severity of symptoms following concussion, relative to athletes not wearing a helmet.

The Project to perform the Trial must include the following required components:

  • Assessments of male and female adult and possibly school age athletes in elite and semi-professional leagues in multiple sports including but not limited to NRL, AFL and Rugby Union. The successful Project must include a range of cohorts of athletes in the study design.
  • Power analysis that indicates that the Trial will be powered with adequate numbers of participants to achieve the purpose of the Trial.
  • A clear and accepted definition of concussion that will enable applicability of the findings across multiple sports and activities.
  • Pragmatic outcome measures that are readily applicable in the general population as well as suitable and feasible for the large scale of the Trial.
  • A report or draft publication delivered within the two-year timeframe that describes the findings, and the limitations of the data generated.

 

As mentioned above, this research call has now closed and the successful application will be announced in February 2026.

Further questions? Please email Connectivity.

Page updated: Wednesday 29 October 2025